AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
-6.8%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$189M
AUM Growth
+$189M
(-17%)
Cap. Flow
-$6.34M
Cap. Flow
% of AUM
-3.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
$6.34M |
Sector Composition
| 1 | Healthcare | 97.29% |
| 2 | Technology | 2.03% |
| 3 | Communication Services | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SURF
1
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $50.8M | 26.9% | 4,645,453 | – | – |
|
|
2
Intellia Therapeutics
NTLA
$1.22B
| $46.2M | 24.47% | 1,615,321 -221,489 | -12% | -$6.34M |
|
3
Synlogic
SYBX
$17M
| $37.7M | 19.94% | 2,651,963 | – | – |
|
4
Cogent Biosciences
COGT
$1.69B
| $34.6M | 18.33% | 3,361,535 | – | – |
|
5
Spero Therapeutics
SPRO
$116M
| $14.5M | 7.66% | 1,376,968 | – | – |
|
|
CBLK
6
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $3.84M | 2.03% | 181,273 | – | – |
|
7
Snap
SNAP
$12.1B
| $1.27M | 0.67% | 150,160 | – | – |
|